Abstract | BACKGROUND: METHODS: In this study, we investigated the therapeutic efficacy of intra-articular injection of bone marrow mesenchymal stem cells (BMSCs) transfected with miR-29a-3p inhibitor in OA. RESULTS: miR-29a-3p inhibitor transfection did not influence cell viability of BMSCs, while the chondrogenic differentiation potential of BMSCs was significantly improved. Interestingly, intra-articular injection of BMSCs with miR-29a-3p inhibition significantly prevented articular cartilage degeneration by up-regulating the expression of Sox 9, Col-2a1, aggrecan and down-regulating the expression of matrix metalloproteinase, as well as relieved pain in OA. CONCLUSION: The double effects on cartilage protection and pain relief indicated a great potential of intra-articular injection of miR-29a-3p inhibitor-transfected BMSCs for the treatment of OA.
|
Authors | Qing Wang, Yong Chen, Xiaofeng Shen, Ji Chen, Yuwei Li |
Journal | Tissue engineering and regenerative medicine
(Tissue Eng Regen Med)
Vol. 18
Issue 6
Pg. 1045-1055
(12 2021)
ISSN: 2212-5469 [Electronic] Korea (South) |
PMID | 34542842
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021. The Korean Tissue Engineering and Regenerative Medicine Society. |
Chemical References |
|
Topics |
- Animals
- Cartilage, Articular
- Injections, Intra-Articular
- Mesenchymal Stem Cells
(metabolism)
- MicroRNAs
(genetics, metabolism)
- Osteoarthritis
(genetics, therapy)
- Pain
(metabolism)
- Rats
|